Zuga Matt Insider Trading Activity

Average Profitability
2.92%
Insider Buys Quantity
1
Insider Buys Sum
$1.12M
Insider Sells Quantity
4
Insider Sells Sum
$96,703.30

Insider Activity of Zuga Matt

According to the SEC Form 4 filings, Zuga Matt, being in a position of

  1. CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25953 shares for $49,556,
    over all time since 2024-01-18, has bought 0 shares, and sold 76696 shares for $146,259.

Biography of Zuga Matt

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$49,5566100

Comparison of Insiders on Amount of Buys and Sells

2026-01-22SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
1,687
0.0026%
$1.86$3,138+26.13%
2026-01-21SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
2,473
0.0041%
$1.81$4,469+38.67%
2026-01-08SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
6,888
0.0111%
$1.82$12,513+33.6%
2026-01-07SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
5,805
0.0096%
$1.99$11,566+24.62%
2026-01-06SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
5,100
0.0084%
$1.97$10,028+26.53%
2026-01-05SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
4,000
0.0065%
$1.96$7,842+25.25%
2025-01-23SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
28,902
0.0479%
$1.72$49,633-19.65%
2025-01-21SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
4,364
0.007%
$1.60$6,986-14.72%
2025-01-03SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
13,235
0.0215%
$1.84$24,367-26.84%
2024-01-18SaleAcumen Pharmaceuticals, Inc.
ABOS
CFO & Chief Business Officer
4,242
0.0075%
$3.71$15,717-23.1%
2019-11-08PurchaseTELA Bio, Inc.
TELA
director
86,121
1.3686%
$13.00$1.12M+2.92%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.